Trichloroethylene induced cancer in animals and its relevance to humans

Journal of Occupational Health

Volumn 39, Issue 4, 1997, Pages 261-273

  Green, Trevor ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Carcinogenicity; Epidemiology; Human hazard assessment; Trichloroethylene

Indexed keywords

CARCINOGEN; MUTAGENIC AGENT; TRICHLOROETHYLENE;

CARCINOGENESIS; CELL DAMAGE; CELL DIVISION; HUMAN; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; MOUSE; MUTAGENICITY; NONHUMAN; RAT; REVIEW;

ANIMALIA;

EID: 0030662508     PISSN: 13419145     EISSN: None     Source Type: Journal    
DOI: 10.1539/joh.39.261     Document Type: Review

References (73)

1. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 20, Some halogenated hydrocarbons. Lyon: International Agency for Research on Cancer, 1979: 545-572.
2. ACGIH (American Conference of Govermental Industrial Hygienists). Trichloroethylene. Notice of intended change. Appl Occup Environ Hyg 1992; 7: 786-791.
3. Japan Society for Occupational Health. Recommendation of occupational exposure limits (1996-1997). J Occup Health 1996; 38: 134-147.
4. IARC Monographs on the evaluation of the carcinogenic risk to humans, Vol. 63, Dry cleaning, some chlorinated solvents and other industrial chemicals. Lyon: International Agency for Research on Cancer, 1995: 95-158.
5. ECETOC. Trichloroethylene: Assessment of human carcinogenic hazard. Technical Report No. 60. Brussels: ECETOC, 1994.
6. 1 mice. Ann NY Acad Sci 1988; 534: 316-342.
7. National Cancer Institute. Carcinogenesis bioassay of trichloroethylene CAS No. 79-01-6. National cancer institute technical report series No. 2. DHEW (NIH) Pub. 76-802; NTIS Pub. No PB-264122. Springfield, VA: National Technical Information Service, 1976.
8. 1 mice. U.S. Dept. of Health and Human Services, NIH Publication No. 82-1799, 1983.
9. Henschler D, Romen W, Elsasser HM, Reichert D, Eder E, Radwan Z. Carcinogenicity study of trichloroethylene by long term inhalation in three animal species. Arch Toxicol 1980; 43: 237-248.
10. Fukuda K, Takemoto K, Tsurata H. Inhalation carcinogenicity of trichloroethylene in mice and rats. Ind Health 1983; 21: 243-254.
11. National Toxicology Program. NTP technical report on the toxicology and carcinogenesis studies of trichloroethylene in four strains of rats. NTP TR 273, April 1988: 22.
12. OECD (Organisation for Economic Co-operation and Develpment). Guidelines for the testing of chemicals 2, guidelines Paris: OECD, 1993: 471-485.
13. Crebelli R, Carere A. Genetic toxicology of 1,1,2-trichloroethylene. Mutation Research 1989; 221: 11-37.
14. Fahrig R, Madle S, Baumann H. Genetic toxicology of trichloroethylene. Mutation Research 1995; 340: 1-36.
15. Davidson IWF, Beliles RP. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmaco-kinetics. Drug Metabolism Reviews, 1992; 23 (5 & 6): 493-599.
16. Green T, Prout MS. Species differences in response to trichloroethylene. II. Biotransformation in rats and mice. Toxicol Appl Pharmacol 1985; 79: 401-411.
17. Dekant W, Schulz A, Meztlerm M, Henschler D. Absorption, elimination, and metabolism of trichloroethylene: a quantitative comparison between rats and mice. Xenobiotica 1986; 16: 143-152.
18. Dekant W, Metzler M, Henschler D. Identification of S-1, 2-dichlorovinyl-N-acetyl cysteine as a urinary metabolite of trichloroethylene: a possible explanation for its nephrocarcinogenicity in male rats. Biochem Pharmacol 1986; 35: 2455-2458.
19. Bruckner JV, Davis BD, Blancato JN. Metabolism, toxicity, and carcinogenicity of trichloroethylene. CRC Critical Reviews in Toxicology, 1989; 20: 31-50.
20. Miller RE, Guengerich FP. Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 1982; 21: 1090-1097.
21. Dekant W, Koob M, Henschler D. Metabolism of trichloroethylene-in vivo and in vitro evidence for activation by glutathione conjugation. Chem Biol Interactions 1990; 73: 89-101.
22. Birner G, Vamvakas S, Dekant W, Henschler D. The nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethylene exposure in humans: implications for the risk of trichloroethylene exposure. Environ Health Perspect 1993; 99: 281-284.
23. Birnauer U, Birner G, Dekant W, Henschler D. Biotransformation of trichloroethylene: dose dependant excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation. Arch Toxicol 1996; 70: 338-346.
24. Green T, Dow J, Ellis MK, Foster JR, Odum J. The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. Chem Biol Interactions 1997; 105: 99-117.
25. Commandeur JNM, Vermeulen NPE. Identification of N-acetyl-S-(2,2-dichlorovinyl)-L-cysteine and N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine as two mercapturic acids of trichloroethylene in the rat. Chemical Research in Toxicology 1990; 3: 212-218.
26. Dekant W, Metzler M, Henschler D, Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. Biochemical Pharmacology 1984; 33: 2021-2027.
27. Prout MS, Provan WM, Green T. Species differences in response to trichloroethylene, I. Pharmacokinetics in rats and mice. Toxicol Appl Pharmacol 1985; 79: 389-400.
28. Buben JA, O'Flaherty EJ. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: A dose-effect study. Toxicol Appl Pharmacol 1985; 78: 105-122.
29. Stott WT, Quast JF, Watanabe PG. The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats. Toxicol Appl Pharmacol 1982; 62: 137-151.
30. Green T. Chloroethylenes: A mechanistic approach to human risk evaluation. Annu Rev Pharmacol Toxicol 1990; 30: 73-89.
31. Ashby JA, Brady A, Elcombe CR, et al. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Human Experimental Toxicol 1994; 13: 1-117.
32. Elcombe CR. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene. A biochemical human hazard assessment. Arch Toxicol Suppl 1985; 8: 6-17.
33. Mirsalis JC, Tyson CK, Loh EN, et al. Induction of hepatic cell proliferation and unscheduled DNA synthesis in mouse hepatocytes following in vivo treatment. Carcinogenesis 1985; 6: 1521-1524.
34. 1 mice. Toxicology Letters 1993; 69: 129-137.
35. Watson SC, Foster JR, Elcombe CR. Trichloroacetic acid: species difference in the stimulation of hepatic DNA synthesis. Human Exptl Toxicol 1993; 12: 577.
36. Herren-Freund SL, Pereira MA, Khoury MD, Olson G. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol Appl Phannacol 1987; 90: 183-189.
37. 1 mouse. Fund Appl Toxicol 1991; 16: 337-347.
38. DeAngelo AB, Daniel FB. An evaluation of the carcinogenicity of the chloroacetic acids in the male F344 rat. Toxicologist 1992; 12: 756 [abstract].
39. Klaunig JE, Ruch RJ, Lin EL. Effects of trichloroethylene and its metabolites on rodent hepatocyte intercellular communication. Toxicol Appl Pharmacol 1989; 99: 454-465.
40. Larson JL, Bull RJ. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol 1992; 115: 268-277.
41. Larson JL, Bull RJ. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol Appl Pharmacol 1992; 115: 278-285.
42. 1 mice. Toxicol Appl Pharmacol 1993, 123: 1-8.
43. Bull RJ, Templin M, Larson JL, Stevens DK. The role of dichloroacetate in the hepato-carcinogenicity of trichloroethylene. Toxicology Letters 1993; 68: 203-211.
44. 1 mice by dichloroacetate and trichloroacetate. Toxicology 1990; 63: 341-359.
45. Ketcha MM, Stevens DK, Warren DA, Bishop CT, Brashear WT. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J Anal Toxicol 1996; 20: 236-241.
46. Knadle SA, Green CE, Baugh M, et al. Trichloroethylene biotransformation in human and rat primary hepatocytes. Toxicology In Vitro 1990; 4: 537-541.
47. Forkert PG, Sylvestre PL, Poland JS. Lung injury indued by trichloroethylene. Toxicol 1985; 34: 143-160.
48. Forkert PG, Birch DW. Pulmonary toxicity of trichloroethylene in mice. Covalent binding and morphological manifestations. Drug Metab Dispos 1989; 17: 106-113.
49. Villaschi S, Giovanetti A, Lombardi CC, Nicolai G, Garbati M, Andreozzi U. Damage and repair of mouse bronchial epithelium following acute inhalation of trichloroethylene. Experimental Lung Research 1991; 15: 601-614.
50. Odum J, Foster JR, Green T. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to tirchloroethylene. Chem Biol Interactions 1992; 83: 135-153.
51. Green T, Mainwaring GW, Foster JR. Trichloroethylene induced mouse lung tumours: Studies of the mode of action and comparisons between species. Fund Appl Toxicol 1997; 37: 125-130.
52. Smith MN, Greenberg SD, Spjut HJ. The Clara cell: A comparative ultrastructural study in mammals. Am J Anatomy 1979; 155: 15-30.
53. Goldsworthy TL, Popp JA. Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity. Toxicol Appl Pharmacol 1987; 88: 225-233.
54. Henschler D, Vamvakas S, Lammert S, et al. Increased incidence of renal cell tumours in a cohort of cardboard workers exposed to trichloroethylene. Arch Toxicol 1995; 69: 291-299.
55. Goeptar AR, Commandeur JNM, van Ommen B, van Bladeren PJ, Vermeulen NPE. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chem Res Toxicol 1995; 8: 3-21.
56. Green T, Odum J. Structure/activity studies of the nephrotoxic and mutagenic action of cysteine conjugates of chloro and fluoralkenes. Chem Biol Interact 1985; 54: 15-31.
57. Lash HL, Xu Y, Elfarra AA, Duescher RJ, Parker JC. Glutathione dependant metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab Dispos 1995; 23: 846-853.
58. Eyre RJ, Stevens DK, Parker JC, Bull RJ. Acid-labile adducts to protein can be used as indicators of the cysteine S-conjugate pathway of trichloroethylene metabolism. J Toxicol-Environ-Health 1995; 46: 443-464.
59. 1 mice. J-Toxicol-Environ-Health 1995; 46:465-481.
60. Terracini B, Parker VH. A pathological study on the toxicity of S-dichlorovinyl-L-cysteine. Food Cosmet Toxicol 1965; 3: 67-74.
61. Jaffe DR, Gandolfi AJ, Nagle RB. Chronic toxicity of S-(trans-1,2-dichlorovinyl)-L-cysteine in mice. J Applied Toxicol 1984; 4: 315-319.
62. Goldsworthy TL, Lyght O, Burnett VL, Popp JA. Potential role of a-2u-Globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane. Toxicol Appl Pharmacol 1988; 96: 367-379.
63. Seldén A, Hultberg B, Ulander A, Ahlborg G Jr. Trichloroethylene exposure in vapour degreasing and the urinary excretion of N-acetyl-b-D-glucosaminidase. Arch Toxicol 1993; 67: 224-226.
64. Bruning T, Golka K, Makropoulos V, Bolt HM. Pre-existence of chronic tubular damage in cases of renal cell cancer after high and long exposure to trichloroethylene. Arch Toxicol 1996; 70: 259-260.
65. Antilla A, Pukkala E, Sallmen M, Hernberg S, Hemminki K. Cancer indidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environm Health 1995; 37: 797-806.
66. Shindell S, Ulrich S. A cohort study of employees of a manufacturing plant using trichloroethylene. J Occup Med 1985; 27: 577-579.
67. Wong O, Morgan R. 1990. Historical prospective mortality study of Hughes Aircraft emphoyees at air force plant #44. ENSR Health Sciences, Document 4700-042-001, Alameda, CA.
68. Spirtas R, Stewart P, Lee S. Retrospective cohort mortality study of workers at an aircraft maintenance facility I. Epidemiological results. Br J Ind Med 1991; 48: 515-530.
69. Axelson O, Selden A, Andersson K, Hogstedt C. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J Occup Med 1994; 36: 556-562.
70. Novotna E, David A, Málek B. An epidemiological study of the hepatic tumour incidence in persons working with trichloroethylene I. The negative result of retrospective investigations in persons with primary liver carcinoma [Czech]. Prac Lekarstvi 1979; 31: 121-123.
71. Paddle GM. Incidence of liver cancer and trichloroethylene manufacture: Joint study by industry and a cancer registry. Brit Med J 1983; 286: 846.
72. Málek B, Krimanová B, Rodavá O. An epidemiological study of hepatic tumour incidence in subjects working with trichloroethylene. II. Negative result of retrospective investigations of dry cleaners [Czech]. Pracov Lek 1979; 31: 124-126.
73. Fredriksson M, Bengtsson N-O, Hardell L, Axelson O. Colon cancer, physical activity, and occupational exposures, a case-control study. Cancer 1989; 63: 1838-1842.